Bone Marrow and Stem Cell Transplant

Dr. Brandon Hayes-Lattin is a specialist in bone marrow-stem cell transplants, and a cancer survivor himself.
Dr. Brandon Hayes-Lattin is a specialist in bone marrow/stem cell transplants, and a cancer survivor himself. He is also medical director of OHSU’s program for young adults with cancer.

A stem cell or bone marrow transplant replaces damaged blood-forming cells with healthy ones. It is a lifesaving treatment for some cancers and blood diseases.

At the OHSU Knight Cancer Institute, we do hundreds of stem cell transplants a year. Our doctors and scientists are leaders in discovering new ways to use cell replacement therapies to help more patients.

We offer:

  • State-of-the-art care in a specially filtered unit, reducing the risk of complications.
  • Oregon’s only program that provides transplants using another person's bone marrow or peripheral blood stem cells.
  • The ability to use donors who are half-matched (haploidentical), making a transplant an option for more patients.
  • Transplants using blood from umbilical cords.
  • Clinical trials to test the latest advances in stem cell transplantation.
  • Follow-up clinics in central and southern Oregon.
  • A survivorship program to help with your long-term needs.
  • A full range of support services to help you manage the transplant process and to address concerns with fertility, finances and other issues.

Oregon’s most advanced care

Our specialists have been doing bone marrow transplants for three decades, giving us the experience to offer outstanding care.

Facilities and training

Our adult transplant clinic has 10 exam rooms with HEPA filtration to minimize the spread of infection-causing germs. The clinic’s infusion unit, where you will receive stem cells by IV, has 17 recliners and five private rooms.

Our inpatient transplant unit in OHSU Hospital has 30 private rooms, all with HEPA filtration. Our nurses are specially trained in treating people with weakened immune systems.

National recognition

Our program, the Northwest Marrow Transplant Program, includes OHSU Hospital, OHSU Doernbecher Children’s Hospital and Legacy Health’s Good Samaritan Medical Center. This collaboration allows us to share expertise among many providers.

The program was the first multihospital effort in the U.S. to meet the rigorous standards for accreditation by the Foundation for the Accreditation of Cellular Therapy. 

Team-based care

OHSU’s Andy Chen, M.D., Ph.D., is an expert in blood cancers and bone marrow transplants.
Andy Chen, M.D., Ph.D., is an expert in blood cancers and bone marrow/stem cell transplants.

To ensure excellent results for our patients, a team of specialists meets regularly and discusses each person who may be eligible for a transplant. As a team, they explore whether the procedure would be beneficial, or lifesaving, for your specific condition. Our team includes:

  • Hematologists (doctors who specialize in treating blood disorders)
  • Medical oncologists (doctors who treat cancer with medications such as chemotherapy)
  • Radiation oncologists (doctors who treat cancer with radiation therapy)
  • Nurse practitioners and physician assistants
  • Nurse coordinators who help you set appointments and navigate other details of your care

Our inpatient team includes:

Support services

A stem cell transplant can be lifesaving. It’s also taxing physically and emotionally. At OHSU, support for you and your family includes:

  • Cancer social workers who can find counselors, support groups and resources to help you prepare for and manage treatment.
  • A Bone Marrow Transplant Survivorship Program to help you arrange long-term follow-up care and handle any complications. This program is also available to patients who had a transplant elsewhere.
  • Clinics in central and southern Oregon where you can receive follow-up care from OHSU providers.
  • Housing assistance if you are traveling to OHSU and need to stay nearby.
  • Financial support for people who need help working with their insurers or paying for a transplant.

Research and clinical trials

Cancer patients at OHSU have access to the latest stem cell transplant advances, including experimental treatments that are not available anywhere else in the region. OHSU Knight Cancer Institute doctors are developing new transplant options and finding ways to reduce the risks of these complicated treatments.

Clinical trials: We offer several clinical trials that give eligible patients a chance to try experimental treatments. Your care team will talk with you about whether a trial is right for you.

Research: OHSU’s blood disorder experts include Knight Cancer Institute Director Brian Druker, who helped develop the lifesaving medication Gleevec for an aggressive form of leukemia. In addition:

  • OHSU was the first hospital in the Northwest to offer the cell replacement therapy Kymriah. It is the first approved treatment in which immune system T cells from each patient are genetically modified to target and eliminate cancer cells.
  • Our doctors are studying a potential way to prevent graft-versus-host disease in cell transplant patients by altering the makeup of the donor cells. Graft-versus-host disease is a life-threatening complication in which the transplanted cells attack the patient’s body.
  • OHSU is one of 21 centers leading a clinical trial of stem cell transplants as a treatment for multiple sclerosis. The transplant is meant to “reboot” the immune system, which malfunctions in MS and damages the brain and nervous system.
  • Our program belongs to the Center for International Blood and Marrow Transplant Research, which contains information on more than 425,000 transplant patients. This offers researchers at OHSU and elsewhere a rich resource for improving care and outcomes for patients. Learn more about our cancer registries.
Coronavirus cell

Resources for Coronavirus

Please contact your clinic by phone or MyChart to confirm appointments.

For patients

Call 503-494-7999 to:

  • Request an appointment
  • Seek a second opinion
  • Ask questions


Parking is free for patients and their visitors.

Center for Health & Healing Building 2
3485 S. Bond Ave.
Portland, OR 97239
Map and directions

Refer a patient

'The man who saved my life'

An OHSU bone marrow transplant patient meets the man whose life-giving donation treated her leukemia.

OHSU helps develop therapy

Read about Dr. Richard Maziarz’s role in winning  FDA approval for Kymriah, an immunotherapy. Dr. Maziarz sees “huge”potential for treating blood and other cancers.

Read about Dr. Richard Maziarz’s role in winning  FDA approval for Kymriah, an immunotherapy. Dr. Maziarz sees huge potential for treating blood and other cancers.

Read more

Learn more about OHSU Knight Cancer Institute treatments: